Useful drug for stem cell transplant problem

by Medindia Content Team on  September 14, 2002 at 4:51 PM General Health News
RSS Email Print This Page Comment bookmark
Font : A-A+

Useful drug for stem cell transplant problem
A new drug rescues patients suffering potentially fatal liver complications from cancer therapy. Generally high doses of chemotherapy are given before a stem cell transplant such as a bone marrow transplant is used for cancer treatment. But chemotherapy causes five to 50 per cent of such patients to experience a potentially fatal complication called veno-occlusive disease (VOD), which damages circulation in the liver.

In this trial, headed by scientists at Dana-Farber Cancer Institute in the US, a group of 80 patients with severe VOD received a new drug. Defibrotide is extracted from pig intestinal tissue. Around a third of the patients experienced complete reversal of VOD and 35 per cent of them survived for at least 100 days after their transplant.

This is important for only 10 per cent of this desperately ill group would be able to survive this long with usual care. The standard treatment for VOD is clot-busting drugs, which have been linked with severe bleeding and are ineffective once the patient has multiple organ failure.


Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Signature Drug Toxicity Graft versus Host Disease (GvHD) 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive